GenSci144 Tablets Phase I Clinical Trial

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Phenylketonuria

In brief

This study is a Phase I single ascending dose clinical trial in which healthy adult volunteers were administered single oral doses of GenSci144 tablets at different levels. It was conducted using a randomized, double-blind, placebo-controlled design, primarily to evaluate the drug's safety and tolerability, while also exploring its pharmacokinetic and pharmacodynamic characteristics in the body, providing a basis for subsequent clinical use in the treatment of phenylketonuria.

Key facts

Study ID
NCT07685210
Run by
Changchun GeneScience Pharmaceutical Co., Ltd.
People needed
48
Starts
2026-06-22
Expected to finish
2026-12-01
Last updated by the study team
2026-07-06

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.